Twenty-one significant differentially expressed proteins, including 9 down-regulated proteins and 12 up-regulated proteins, were identified after DATS administration, and most of them were involved in apoptosis. Our results suggest that DATS is an inducer of apoptosis in HSCs, and several key proteins may be involved in the molecular mechanism of apoptosis induced by DATS.
Introduction
Liver fibrosis is a disease affecting an estimated 100 million people worldwide (Curry 2013; Morgan et al. 2013) . Liver fibrosis and associated cirrhosis are caused by chronic viral hepatitis, alcohol toxicity, autoimmune diseases and hereditary metabolic disorders. It is now generally accepted that a central pathologic mechanism underlying liver fibrosis is the generation and proliferation of smooth muscle α-actin (α-SMA)-positive myofibroblasts of periportal and perisinusoidal origin that arise as a consequence of the activation of hepatic stellate cells (HSCs) and other cell types, such as periportal fibroblasts (Bataller and Brenner 2005; Senoo 2004 ). HSCs are critically involved in the development of liver fibrosis because they are responsible for the excessive deposition of extracellular matrix (ECM) proteins in the liver.
Therefore, it is critical to reduce the number of activated HSCs for the reversibility of liver fibrosis ). There are three major pathways that may help eliminate the activated HSCs: apoptosis, senescence or reversal to an inactivated phenotype. In recent years, Induction of apoptosis as elimination of HSCs has been suggested to be effective in the control of hepatic fibrosis (Fallowfield 2011; Tacke and Weiskirchen 2012) . Diallyl trisulfide [DATS; 3-(prop-2-enyltrisulfanyl)prop-1-ene, CH 2 =CHCH 2 -SSS-CH 2 CH=CH 2, (Molecular weight, 178.20) ], a characteristic flavor produced by garlic, contains three sulfur atoms with two allyl groups. Previous studies also indicated that garlic had multiple liver protection properties (Borek 2001; Chen et al. 2012; Zeng et al. 2008) . The underlying mechanisms consist of hepatocyte protection including TGF-β1 inhibition and reduced hepatic oxidative stress (D'Argenio et al. 2013; Zhu et al. 2014) . DATS has been reported to inhibit proliferation of cultured cancer cells by causing cell cycle arrest and inducing apoptosis (Zhang et al. 2007) . A recent study also suggested that DATS could cause cell cycle arrest and induce apoptosis associated with reactive oxygen species (ROS) production in breast cancer cells (Chandra-Kuntal et al. 2013 ). However, it still remains unclear whether DATS could induce apoptosis of HSCs or not.
To determine suitable doses of DATS for our study, we carefully reviewed the available data. Several previous studies had reported that DATS at a concentration range of 10 to 100 µM induced apoptosis in several human cancer cells Xiao et al. 2009) . In this study, we first explored the effects of DATS at two concentrations (12 and 24 µg/mL, equivalent as 67.5 and 135 µM) on apoptosis in rat HSCs. We observed that the exposure to 24 µg/mL DATS led to significant D r a f t morphological changes and inhibition of cell proliferation in rat HSCs.
Proteomics is an emerging field in medical science focusing on the library of transcripts specific to a given bio-system. Pharmacoproteomics is the application of proteomic technologies in drug development and assessment of drug administration (D'Alessandro and Zolla 2010; Yu 2011) . Analyses of the transcriptome and the proteome of human HSCs have been reported with valuable data (Buchholz et al. 2005; Paulo et al. 2013 ) to promote our understanding of the physiology of HSCs.
Our data implied that several cell cycle-associated or apoptosis-associated proteins in HSCs were induced by DATS treatment.
Materials and methods

Reagents
DATS was purchased from ChromaDex Company (USA). All chemical reagents for 2-DE were purchased from Amersham Biosciences (Uppsala, Sweden), and HPLC grade solvents were obtained from J.T. Baker (Phillipsburg, New Jersey, USA).
Trypsin and dimethyl sulfoxide (DMSO) were purchased from Sigma (St. Lousis, Missouri, USA). The protein concentration was determined by the Bradford method using a 2D Quant kit (Amresco) according to the manufacturer's instructions. Proteins were initially separated using an Ettan IPGphor 3 Isoelectric Focusing System (GE Healthcare).
Cell culture and DATS treatment
Rat hepatic stellate cells (HSC-T6) were obtained from Cancer Institute and Hospital, Chinese Academy of Medical Sciences (Beijing, China). Cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen, California, USA) containing 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37 °C in a humidified 5% CO 2 incubator. After reaching 60% confluence, the cells were treated with 12 µg/mL or 24 µg/mL DATS for 6 h, 12 h and 24 h, respectively. DATS was dissolved in 0.1% DMSO. Cells treated with DMSO alone were regarded as the control.
MTT assay
The effect of DATS on cell viability was measured by the MTT [3-(4-5dimethylthiozol-2-yl)-2, 5-diphenyltetrazolium bromide] assay (Li et al. 2013) , which was based on the ability of live cells to convert thiazolyl blue to dark blue formazan. Exponentially growing HSCs were seeded into 96-well culture plates at 4 × D r a f t 10 3 cells per well and treated with or without DATS for 6 h, 12 h and 24 h, respectively. After treatment, MTT (5 mg/mL) was added into each well for continual incubation at 37 °C for 4 h followed by DMSO into each well to dissolve the formazan product for 30 min at room temperature. A 96-well microplate reader (Rayto, USA) was used to measure the absorbance at 570 nm (A570). At least three independent experiments were carried out.
BrdU assay
HSCs were cultured as described above. Cells were seeded in 6-well culture plates at a density of 1×10 5 cells/well in a plating medium consisting of F10 medium supplemented with 10% FCS and penicillin/streptomycin. After 48 h, the culture medium was replaced with F10 medium containing 0.1% FCS and BrdU (100 µM).
After 24 h of serum starvation, DATS was added to the medium and the cultures were incubated at the indicated dose and time. The medium was aspirated and immediately fixed with anti-BrdU. The cells were washed in PBS and processed for immunofluorescence.
Morphological study of apoptotic cells
HSCs were collected and washed 3 times in PBS, and then incubated with the Hoechst 33342 (fluorescent DNA dye). The morphology of apoptosis was studied using fluorescence microscopy. Cells were treated with 24 µg/mL DATS for 12 h and conventionally fixed in 2.5% glutaraldehyde solution, dehydrated, penetrated, ultrathin sliced and electron-stained. Ultrastructural changes were observed with a transmission electron microscope (TEM).
Cell cycle analysis by flow cytometry
Flow cytometry was performed with annexin V/fluorescein isothiocyanate (FITC)
Apoptosis Detection Kit (Bender, Austria) (Xiao et al. 2009 ) to determine the apoptosis of HSCs treated with 24 µg/mL DATS for 6 h, 12 h and 24 h, respectively.
After treatment with DATS or DMSO, the harvested cells were washed twice with precooled PBS and suspended in 250 uL binding buffer to modulate the cell concentration at 1×10 6 cells/mL. Then, 100 µL of the cell suspension was pipetted into a 5 mL test tube, with 5 µL annexin V/FITC and 10 µL PI added to it. After this mixture was incubated for 15 min at room temperature, 400 µL PBS was added to the test tube. The rate of apoptotic cells was analyzed on FACSC alibur, and a cell isometric chart composed of four quadrants was acquired after analysis. The total number of apoptotic cells included earlier apoptotic cells and secondary apoptotic D r a f t cells. Three independent experiments were performed, and the data was presented as mean ± standard deviation (SD).
Sample preparation for two-dimensional electrophoresis
HSCs were washed three times with ice-cold PBS and lysed using lysis buffer 
Isoelectric focusing electrophoresis
The isoelectric focusing electrophoresis was performed as previously described (Garcia-Hernandez et al. 2012) . Briefly, 120 µg proteins were solubilized directly in rehydration buffer, 1% DTT, 1% IPG-buffer and 0.002% bromophenol blue, and the total volume was 460 µL. Proteins were initially separated using an Ettan IPGphor 3
Isoelectric Focusing System (GE Healthcare). Different groups of HSC proteins were focused to their isoelectric points on a 24 cm (pH 4~7) Immobiline DryStrip (GE Healthcare) using the following parameters: 300 V for 30 min, 700 V for 30 min, 1,500 V for 1.5 h, 9,000 V for 3 h, and finally 9,000 V for 4 h. After the isoelectric focusing, the immobilized pH gradient (IPG) strip was equilibrated for 15 min in
The gels were scanned at a resolution of 200 dots/in (dpi) using a scanner (Powerlook1100, UMAX) and analyzed by ImageMaster™ 2D Platinum 5.0 software (GE Healthcare) for spot detection, spot matching and quantitative intensity analysis.
Relative quantitative analysis of each spot between the control group and DATS treated group on the triplicate gels was performed using Student's t-test. The differentially expressed protein spots were manually excised from the silver stained gels and loaded into a 96-well microplate. The gel fragments were washed twice with
MilliQ water, destained with 50% methanol at 37 °C for 30 min, and dehydrated in 100 µL of acetonitrile (ACN) at room temperature for 20 min. Next, the samples were swollen in 50 µL of 100 mM NH 4 HCO 3 , dehydrated for the second time and incubated in 1 µg/50 µL trypsin (Promega) at 4 °C for 30 min. Then, the samples were supplemented with coverage solution (10% ACN, 50 mM NH 4 HCO 3 , Milli-Q water) and incubated at 37 °C for 16 h.
After suction of the coverage solution, the peptide mixtures were extracted using 2.5% trifluoroacetic (TFA)/90% ACN at room temperature for 30 min and finally vacuum-dried. After vacuum drying, the material was dissolved in 1.5 µL solution 
Database search
The experimental MS data were matched to a corresponding virtual peptide mass database derived from GPS Explorer™ v3.6, the Mascot, and the International Protein Index (IPI) mouse protein database. All acquired spectra of samples were processed using the Mascot software (http://www.matrixscience.com). The search parameters were as follows: database: IPI mouse; enzyme: trypsin; fixed modifications:
carbamidomethylation; and variable modifications: oxidation (M). The function, gene name, and Gene Ontology (GO) category of each protein were determined using the Mascot v2.1 software protein database search engine and the IPI mouse protein database. We selected a reference gel against which each of the other gel images was matched. Three gels per sample underwent automatic spot detection and manual editing before automatic spot matching both within and between groups. Manual D r a f t matching was conducted as needed. Base-pair normalization was carried out on all the gels before examination of spot volume data. Gels were normalized in accordance with ImageMaster software protocols using base-pair normalization.
Statistical analysis
Values were expressed as mean ± SD and analyzed by one-way analysis of variance (ANOVA) and Fisher's least significant difference test to determine significant differences among group means (P < 0.05).
Results
DATS inhibited cell viability in HSCs
In this study, the effect of DATS on the viability and proliferation of HSCs was assessed using the MTT assay and BrdU assay, respectively. The anti-proliferative effect of DATS on HSCs was assessed by exposing them to different concentrations of DATS (12 µg/mL or 24 µg/mL) for 6 h, 12 h and 24 h, respectively. Exposure of HSCs to DATS resulted in a decrease in cell viability and proliferation in a timedependent manner ( Fig.1A and 1B) . A significant inhibition of cell growth was observed after 24 h of incubation with DATS at different concentrations. When HSCs were treated with 24 µg/mL DATS for 24 h, the cell viability measured by MTT assay was decreased to 55.7 ± 3.8% (Fig. 1A ) and the cell proliferation measured by BrdU assay was decreased to 28.5 ± 0.8% (Fig. 1B) .
Effects of DATS on HSC morphology and cell cycle
To explore the effect of DATS on HSC morphological changes and apoptosis, the membrane permeable DNA-binding dye Hoechst 33342 was used to stain the nuclei of HSCs. DATS caused apoptotic cell death characterized by nuclear condensation and fragmentation as well as bright staining visible under the fluorescent microscope (Fig. 2) . We observed that DATS induced apoptosis in both high and low doses. The percentage of apoptotic cells treated with 24 µg/mL DATS was significantly higher than that in 12 µg/mL DATS-treated cells. The shape of the cells changed from stellate or shuttle to spherical, and the intercellular space was increased. After the 12 h incubation, the cells began to detach from the flask. Using the transmission electron microscope (TEM), we observed decreased volume, condensed chromatin and decreased nucleo-cytoplasmic ratio of apoptotic cells. Some cells showed typical apoptotic changes including pyknosis and margination of the nuclear chromatin.
However, TEM showed nuclear fragmentation, annular or crescent body, cytoplasmic D r a f t vacuoles and swollen mitochondria as well as karyolysis of cells resulting in specific apoptotic bodies (Fig. 3) . In addition, HSCs were incubated with 24 µg/mL DATS for 6 h, 12 h and 24 h, and analyzed using annexin V-FITC/PI staining with flow cytometry (Fig. 4) . The results showed that DATS induced apoptosis of HSCs in a time-dependent manner. Compared with the vehicle control (DMSO), DATS significantly induced apoptosis of HSCs after 12 h and 24 h treatment, regardless of the 6 h treatment (Fig. 4A) . Quantitatively, DATS treatment for 12 h and 24 h resulted in a statistically significant increase of apoptosis rates, compared with the untreated control group (12 h treatment: 13.97% ± 0.37% vs. 8.83% ± 1.64% and 24 h treatment:
21.27% ± 0.93% vs. 9.44% ± 0.77%, respectively) (Fig. 4B) .
Furthermore, we also detected the effects of DATS treatment on cell cycle regulation in HSCs ( HSCs was higher by about 1.2 to 1.6 folds after treatment with 24 µg/mL DATS for 12h and 24h, respectively, compared with the DMSO-treated controls (Fig. 5B) .
Two-dimensional electrophoresis (2-DE) pattern
We used 2-DE in conjunction with quantitative image analysis and peptide sequencing by mass spectrometry to investigate the changes of protein expression in
HSCs treated with or without DATS. According to the 2-DE imaging, the proteins in HSCs treated with or without DATS were electrophoretically similar in molecular mass and pI (Fig. 6) . The spots were biased toward the specific pH regions on the IPG strips, whereas they were evenly distributed over the range of molecular mass from 10 to 170 kDa on 12% SDS-polyacrylamide gel. The total spots were 1893 ± 107 (n = 3) and 1734 ± 97 (n = 3) in the control and DATS-treated groups, respectively. After normalization, the spot densities were determined based on total quantity in the analysis set. Protein spots that showed significant and consistent increase or decrease in density (paired t-test, P < 0.05) were selected and defined as up-or down-regulated spots. A total of 21 spots were defined as DATS-sensitive in HSCs, including 9 downregulated spots and 12 up-regulated spots.
Identification of differentially expressed proteins
The spots from the 2-DE gel were subjected to trypsin digestion and MALDI-TOF- Another four spots (including two up-regulated and the other two down-regulated)
were identified as heterogeneous nuclear ribonucleoprotein K.
Discussion
In this study, we treated HSCs with 12 µg/ml DATS and 24 µg/ml DATS for 6 h, 12
h and 24 h, respectively. We observed clear apoptosis following 12 h treatment with DATS (24 µg/mL). Significant differences in decreased viability of HSCs and induction of apoptosis were observed at higher concentration when compared with the lower concentration and the control group. The results show that the percentage of apoptotic cells was time-dependent on DATS treatment suggesting that DATS induced apoptosis of HSC in vitro. Accordingly, obvious morphological changes of apoptosis were observed using TEM, and cell cycle changes were analyzed using flow
cytometry. These results demonstrate that DATS manifested anti-proliferation and D r a f t apoptosis-inducing activities against HSCs. The results show for the first time that DATS induced apoptosis of HSCs. The findings provide an insight into the potential anti-fibrotic mechanism of DATS. Accordingly, an in vivo study had showed that garlicin at 11mg/kg exhibited protective effect on hepatic fibrosis induced by dimethylnitrosamine in rat. Based on pharmacokinetics, the in vivo dosage of 11 mg/kg was basically equivalent to the in vitro dosage of 24 µg/mL, when liver firstpass effect is ignored in rat. In addition, we also showed that 21 spots were defined as proteins with 18 unique ones, including 14 directly or indirectly related to apoptosis.
Annexins were among the most significantly up-regulated proteins by DATS.
Annexins are a family of structurally related, Ca 2+ -sensitive proteins that bind to negatively charged phospholipids and establish specific interactions with other lipids and lipid microdomains. Annexins participate in a variety of intracellular processes, ranging from the regulation of membrane dynamics to cell migration, proliferation, and apoptosis (Monastyrskaya et al. 2009 ). Annexin A3 is a special member of Annexin family. Yan et al. showed that increased Annexin A3 expression contributed to platinum resistance in ovarian cancer. Furthermore, Annexin A3 inhibited apoptosis induced by cisplatin in human epithelial ovarian cancer cells (Yan et al. 2010 ). In contrast, we found that Annexin A3 was significantly higher in DATStreated group than that in control groups. Therefore, we hypothesized that Annexin A3 may participate in the apoptosis of HSCs and play a role of pro-apoptotic effect.
Our data indicate that increased expression of Annexin A3 may be a specific mechanism of apoptosis induction in HSCs.
In addition, we found that DATS increased the expression of elongation factor 1-delta. Elongation factor-1 (EF-1) delta is a subunit of EF-1, which is a protein complex that participates in the elongation step of mRNA translation and has recently been considered to be correlated with oncogenic transformation (Lei et al. 2010; Ogawa et al. 2004 ). However, no study has been conducted regarding the significance of EF-1 delta mRNA expression in HSCs. This observation appears to indicate that changes in translational processes occur in early phase of apoptosis of HSCs , which might eventually influence the expression levels of different set of proteins.
Nucleophosmin (NPM) is a ubiquitously expressed chaperone protein that shuttles rapidly between the nucleus and cytoplasm, while it predominantly resides in the nucleolus. It plays key roles in ribosome biogenesis, centrosome duplication, genomic stability, cell cycle progression and apoptosis (Rau and Brown 2009 Glucose-regulated protein 75 (Grp75) Additionally, aldehyde dehydrogenases (ALDH) are a group of enzymes that catalyze the oxidation (dehydrogenation) of aldehydes (Marchitti et al. 2008 ). ALDH2
has been proved to be involved in oxidative stress-induced cell apoptosis (Hu et al. 2011 ), while little is known in HSCs. In the present study, we found that ALDH protein expression was down-regulated by DATS in HSCs, suggesting that ALDH might play a vital role in protecting DATS-induced apoptosis in HSCs.
Molecular chaperones play an important role in the folding of many proteins and the CCT complex is a member of the two major chaperone systems that promote the folding and assembly of a wider range of cytosolic substrates. T-complex protein 1 subunit epsilon is one of subunits of Chaperonin-containing TCP-1 (CCT), a heterooligomeric ring complex composed of eight subunits (α, β, γ, δ, ε, ζ, η and θ) (Bouhouche et al. 2006; Llorca et al. 2001) . CCT is necessary for the folding of actin and tubulin in the cytosol. The relationship between T-complex protein 1 subunit epsilon and cell apoptosis still remains unclear.
Interestingly, we observed that two heterogeneous nuclear ribonucleoprotein K (hnRNP K) protein spots presented an increase, whereas another two hnRNP K protein spots presented a decrease. The hnRNP K is a highly conserved RNA-binding protein that was initially identified as part of the hnRNP complex (Dreyfuss et al.
D r a f t
1993). The hnRNP K contains multiple modules that simultaneously engage proteins and nucleic acids and appear to facilitate molecular interactions (Bomsztyk et al. 1997; Gao et al. 2009; Matunis et al. 1992) . The hnRNP K has been implicated in apoptosis and mediates several signal transduction pathway, but its precise role in apoptosis has not been clearly defined (Gao et al. 2009; White et al. 2010) . A recent study reported that hnRNP K plays an anti-apoptotic role in HCC cells, independent of p53 status, via maintenance of high levels of endogenous caspase inhibitors (Xiao et al. 2013 ). Our results indicated that different isoforms or modification of hnRNP K may play different roles during DATS treatment of HSCs. Nevertheless, this study suggested that hnRNP K may play a complicated role in HSCs, and hnRNP K might be as a possible therapeutic marker for hepatic fibrosis. Similarly, there was one protein spot of elongation factor thermo unstable (EF-Tu) presenting an increase and another EF-Tu protein spot presenting a decrease. EF-Tu is one of the prokaryotic elongation factors and a GTP-binding protein that delivers aminoacyl-tRNA to the A site of the ribosome during protein synthesis (Daviter et al. 2003) . This result indicated that the up-regulated EF-Tu may not be specific to DATS-treated HSCs.
However, further studies are warranted to investigate whether EF-Tu plays a role in the apoptosis of HSCs.
In summary, our study suggested that DATS induced apoptosis of HSCs.
Furthermore, we detected significant expression changes in proteins related to apoptosis of HSCs using comparative 2DE-analysis. To the best of our knowledge, some of these proteins, which are related to the pathophysiological mechanisms of liver fibrosis, have never been described in this disease. Several differentially expressed proteins were identified by MALDI-TOF-TOF and some of them may be related to apoptosis, supporting the hypothesis that DATS is an inducer of apoptosis in HSCs. The proteomic data provide clues for the investigation of potential molecular markers for DATS-induced apoptosis in HSCs. These findings also provide an insight into the molecular mechanism of anti-fibrotic function of DATS. Although the exact molecular mechanisms underlying significant protein changes in the HSCs after DATS treatment should be further studied, our results provide valuable insight into the development of potential treatment strategies for liver fibrosis using DATS. D r a f t Fig. 1 . DATS inhibits HSC cell proliferation by MTT or BrdU assays. HSCs (5000 cells per well) were plated into a 96-well plate. Cells were incubated with 10% FBS, 0.1% DMSO, 12 µg/mL DATS or 24 µg/mL DATS. MTT and BrdU assays were performed after the cells were cultured for 6 h, 12 h and 24 h respectively. n = 3. *P < 0.05 and **P < 0.01, compared with 0.1% DMSO.
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